Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1942
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study ; volume:44 ; number:12 ; day:23 ; month:10 ; year:2021 ; pages:1355-1364 ; date:12.2021
Drug safety ; 44, Heft 12 (23.10.2021), 1355-1364, 12.2021
- Creator
-
Sakai, Fumihiko
Suzuki, Norihiro
Ning, Xiaoping
Ishida, Miki
Usuki, Chiharu
Iba, Katsuhiro
Isogai, Yuki
Koga, Nobuyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40264-021-01119-2
- URN
-
urn:nbn:de:101:1-2022020221310826204861
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 7:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sakai, Fumihiko
- Suzuki, Norihiro
- Ning, Xiaoping
- Ishida, Miki
- Usuki, Chiharu
- Iba, Katsuhiro
- Isogai, Yuki
- Koga, Nobuyuki
- SpringerLink (Online service)
Other Objects (12)
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Migraine predicts physical and pain symptoms among psychiatric outpatients
Unmet Needs in Preventive Treatment of Migraine
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial
Preventive treatment can reverse cognitive impairment in chronic migraine
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Preventive non–pharmacological treatment and nitric oxide in chronic migraine
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Migraine predicts physical and pain symptoms among psychiatric outpatients
Unmet Needs in Preventive Treatment of Migraine
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial
Preventive treatment can reverse cognitive impairment in chronic migraine
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Preventive non–pharmacological treatment and nitric oxide in chronic migraine
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Migraine predicts physical and pain symptoms among psychiatric outpatients
Unmet Needs in Preventive Treatment of Migraine
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial
Preventive treatment can reverse cognitive impairment in chronic migraine
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies